HOME >> BIOLOGY >> NEWS
Doctors aware of Tylenol-related liver risk - but is the public getting the message?

ANN ARBOR, MI - The message that a common pain reliever can have uncommonly bad effects on the liver under certain conditions seems to have reached most physicians, a new study finds. Now, the challenge lies in getting the word out to their patients and the public.

The newly published study surveyed physicians to assess how well they understand the potentially liver-damaging effects of acetaminophen, commonly sold as Tylenol or as an ingredient in other medications. The results are published in this month's Journal of Clinical Outcomes Management by researchers from the University of Michigan Health System and School of Public Health.

Acetaminophen can lead to potentially fatal liver damage if taken in large doses - either intentionally in a suicide attempt or unintentionally in a prolonged attempt to quell pain - or if taken in conjunction with alcohol, certain other medications or fasting, or by people with existing liver problems. Intentional overdoses are the most common cause of such liver problems, but other causes are gaining notice.

The survey also looked at physicians' understanding of how to treat acetaminophen-related liver problems, their knowledge about how common such problems are, and their attitudes toward recommending liver transplants for those whose livers had been damaged by acetaminophen.

"It appears that most doctors' knowledge is good, with more than 95 percent of them aware of certain risk factors, though there's still room for improvement," says Robert Fontana, M.D., assistant professor of internal medicine at UMHS and senior author of the report. "We should encourage physicians to talk with their patients about all the risk factors, while at the same time, finding more ways to educate the public about this avoidable risk."

While acetaminophen products are safe for most people when used as directed, its toxic effect on the liver can be dramatic under certain conditions. The drug can hamper the liver, or even cause
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
17-Jun-2001


Page: 1 2 3

Related biology news :

1. Doctors miss chances to help pregnant women quit smoking
2. Doctors miss chance to advise women of vitamin that prevents birth defects, survey finds
3. Doctors perform more IVF treatments, but multiple births decline
4. Doctors failure to reevaluate asthma severity hurts wheezing sufferers
5. One In Three Doctors Recommends Herbal Supplements To Patients
6. Doctors Find Lead On Common Genes Which Can Lead To Bowel Cancer
7. Plant Doctors Find Genetic Solution For Papaya Growers
8. Phase Out Planned For One Of Top Five U.S. Pesticides, Plant Doctors Respond
9. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
10. Scientists raise awareness of need for sound science in age of fad diets
11. University of Delaware lays keel for new research vessel

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... (PRWEB) , ... August 14, 2019 , ... Representatives with ... Convention and Exhibition Center in Boston. , “We help innovative projects connect with Chinese ... spokesperson for MyBioGate. , Guo went on to explain that as a part of ...
(Date:8/6/2019)... ... 2019 , ... A study released today in STEM CELLS ... for personalized medicine, especially when seeking treatments for children with heart failure. The ... cell donors and manipulation methods might yield the best therapies for these patients. ...
(Date:8/4/2019)... (PRWEB) , ... August 02, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit http://www.xtalks.com to see our upcoming webinars: ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff ... Indicator was recognized as the 2019 Innovative Product of the Year which highlights ... awards were during Sensors Expo & Conference 2019, held this week ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 10, 2019 , ... ... today announced IOPP will add 80 of its scientific journals to DeepDyve’s rental ... physics-related content to DeepDyve’s continually expanding library of more than 20 million articles, ...
Breaking Biology Technology:
Cached News: